Detalhe da pesquisa
1.
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.
Ann Oncol
; 30(5): 815-822, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860590
2.
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Ann Oncol
; 30(4): 582-588, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715153
3.
Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure.
J Eur Acad Dermatol Venereol
; 33(10): 1874-1885, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087403
4.
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma.
Ann Oncol
; 28(5): 1130-1136, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327969
5.
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
Ann Oncol
; 28(3): 634-641, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993793
6.
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.
Ann Oncol
; 26(2): 415-21, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25411413
7.
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.
Ann Oncol
; 26(11): 2267-74, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26410620
8.
Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks.
Br J Dermatol
; 172(1): 239-43, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25040674
9.
Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.
Intern Med J
; 45(10): 1066-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26010858
10.
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.
Br J Cancer
; 111(2): 292-9, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24918823
11.
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma.
Br J Cancer
; 108(4): 924-31, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23403819
12.
Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors.
Br J Dermatol
; 169(6): 1310-3, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23870055
13.
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma.
Ann Oncol
; 28(7): 1672-1673, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407116
14.
Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.
Br J Dermatol
; 167(5): 1153-60, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22804352
15.
Targeting BRAF for patients with melanoma.
Br J Cancer
; 104(3): 392-8, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139585
16.
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
Br J Cancer
; 100(8): 1245-9, 2009 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19367282
17.
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
Br J Cancer
; 100(8): 1250-6, 2009 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19367283
18.
Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy.
Ann Surg Oncol
; 15(6): 1741-9, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18379853
19.
Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Cancer Res
; 42(1): 324-30, 1982 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-6976204
20.
Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells.
Cancer Res
; 48(18): 5203-9, 1988 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-3136918